KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bionano Genomics (BNGO) EPS (Basic) (2017 - 2025)

Historic EPS (Basic) for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to -$1.59.

  • Bionano Genomics' EPS (Basic) rose 9485.77% to -$1.59 in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.68, marking a year-over-year increase of 9737.92%. This contributed to the annual value of -$88.13 for FY2024, which is 7843.05% up from last year.
  • Per Bionano Genomics' latest filing, its EPS (Basic) stood at -$1.59 for Q3 2025, which was up 9485.77% from -$1.99 recorded in Q2 2025.
  • Over the past 5 years, Bionano Genomics' EPS (Basic) peaked at -$0.04 during Q1 2021, and registered a low of -$77.14 during Q4 2023.
  • Over the past 5 years, Bionano Genomics' median EPS (Basic) value was -$1.24 (recorded in 2023), while the average stood at -$9.92.
  • Its EPS (Basic) has fluctuated over the past 5 years, first tumbled by 566797.98% in 2023, then skyrocketed by 9678.32% in 2025.
  • Over the past 5 years, Bionano Genomics' EPS (Basic) (Quarter) stood at -$0.08 in 2021, then crashed by 1512.92% to -$1.34 in 2022, then plummeted by 5667.98% to -$77.14 in 2023, then skyrocketed by 79.47% to -$15.83 in 2024, then surged by 89.96% to -$1.59 in 2025.
  • Its EPS (Basic) was -$1.59 in Q3 2025, compared to -$1.99 in Q2 2025 and -$1.15 in Q1 2025.